# Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

> **NCT03723512** · NA · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 7 (actual)

## Conditions studied

- C3 Glomerulonephritis
- C3 Glomerulopathy
- Immune Complex Membranoproliferative Glomerulonephritis
- IC-MPGN
- Dense Deposit Disease

## Interventions

- **DEVICE:** Non contrast-enhanced magnetic resonance imaging

## Key facts

- **NCT ID:** NCT03723512
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-06
- **Primary completion:** 2021-02-17
- **Final completion:** 2021-02-17
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03723512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03723512, "Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03723512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*